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Abstract The influence of two organic selenocom-
pounds and sodium selenite on oxidant processes in rat
brain tissue was investigated. The study was per-
formed on male Wistar rats. The animals were divided
into four groups: I—control; II—administered with
sodium selenite; III—provided with selenoorganic
compound A of chain structure 4-(o-tolyl-)-seleno-
semicarbazide of 2-chlorobenzoic acid and IV—
provided with selenoorganic compound B of ring
structure 3-(2-chlorobenzoylamino-)-2-(o-tolylimi-
no-)-4-methyl-4-selenazoline. Rats were treated by
stomach tube at a dose of 5 9 10-4 mg of selenium/g
of b.w. once a day for a period of 10 days. In brain
homogenates total antioxidant status (TAS), activities
of superoxide dismutase (SOD) and glutathione per-
oxidase (GPx), concentrations of ascorbic acid (AA)
and reduced glutathione (GSH) as well as concentra-
tion of malonyl dialdehyde (MDA) were determined.
TAS was insignificantly diminished in all selenium-
supplemented groups versus control. SOD was not
significantly influenced by administration of selenium.
GPx was markedly decreased in group III versus
control, whereas increased in group IV versus control
and group III. Selenosemicarbazide depleted AA in
well-marked way versus group II. GSH was signif-
icantly depressed in group III versus both control and
group II and diminished in group IV versus group II.
MDA was significantly decreased in group III versus
both control and group II, whereas in group IV
increased versus group III. As selenazoline A did not
decrease elements of antioxidant barrier and increased
GPx activity, it seems to be a promising agent for
future studies concerning its possible application as a
selenium supplement.
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Selenium is an essential trace element, necessary to
correct organism’s functions (Yan et al. 2013). Its
deficit may result in severe disorders including cancer
(Klarod et al. 2011), dermatic and mood disorders
(Ingen-Housz-Oro et al. 2004; Sopjani et al. 2008),
illnesses of alimentary tract (Skelton et al. 2006), as
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well as AIDS development after HIV-infection (Ray-
man 2000). Selenium is also suggested to be involved
into functioning of cartilage (Yan et al. 2013).
Numerous research studies precede our studies on
safe and effective supplements (Combs 2005; Rˇezanka
and Sigler 2008; Selamoglu Talas et al. 2009) using
diverse substances both inorganic (sodium selenite or
selenate) (Ivancic and Weiss 2001; Ayaz and Turan
2006; Uezono et al. 2006) and organic (Xia et al. 2004;
Burk et al. 2006; Pawlas and Małecki 2007; Cui et al.
2008; Selamoglu Talas et al. 2009) as well as
selenium-enriched natural products e.g.: malt (Liu
et al. 2006), yeast (Burk et al. 2006), broccoli
(Rˇezanka and Sigler 2008), but the question of the
best form remains unsolved. The main difficulties
result from the narrow range between therapeutic and
toxic dose of selenium (Hawkes et al. 2008) as well as
from the dependence of its bioavailability on the form
of supplementation (Burk et al. 2006). Since selenium
is considered to be an antioxidant, as a constituent of
one of the main antioxidative enzymes—glutathione
peroxidase (Ha and Smith 2009), many investigations
have concerned relationships between selenium and
oxidative balance in organisms (Ghodbane et al. 2011;
Horky et al. 2012; Zhang et al. 2013). Ebselen, a ring
selenoorganic compound of isoselenazole structure
has been found to possess antioxidant properties
although its negative effects have also been stated
(Farina et al. 2004; Shi et al. 2006). An organosele-
nium compound has also been shown to exert protec-
tive effect against side effects of cisplatin by the
affecting of pro- and antioxidative processes (Ghosh
et al. 2013).
Selenium is widely distributed throughout the body,
and its high level occurs in the brain (van Eersel et al.
2010). As an antioxidant or a main constituent of brain
selenoproteins, it appears to be an important factor in
maintaining of brain functions (Akbaraly et al. 2007).
Associations between low selenium levels and a
significantly greater incidence of depression and other
negative mood states such as anxiety, confusion, and
hostility (Rayman 2000) as well as cognitive impair-
ment, Alzheimer’s disease (van Eersel et al. 2010) or
brain tumors (Chen and Berry 2003) have been
reported. Researchers have indicated that neurological
disorders are often associated with oxidative stress
(Chauhan et al. 2004; Mariani et al. 2005) and
selenium compounds may display antioxidant and
neuroprotective properties (Akbaraly et al. 2007).
Having regarded these findings the aim of the present
study was to evaluate the influence of the two newly
synthesized organic selenocompounds with that
exerted by acknowledged inorganic supplement
sodium selenite, which is still used in clinical practice
(Pagmantidis et al. 2008; Schnabel et al. 2008; Savory
et al. 2012) and as a supplement of animal food




Two selenoorganic compounds were synthesized in
our chair: compound A (chain structure) 4-(o-tolyl-)-
selenosemicarbazide of 2-chlorobenzoic acid (Musik
et al. 2002) and compound B (ring structure) 3-(2-
chlorobenzoylamino-)-2-(o-tolylimino-)-4-methyl-4-
selenazoline (Musik et al. 2009).
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Animal experiment
The experiment was carried out on adolescent male
Wistar rats. After 3 days of acclimatization the
animals were randomly divided into four groups (ten
animals each): group I (control with no selenium
supplementation)—treated with saline, group II—
treated with sodium selenite, group III—treated with
4-(o-tolyl-)-selenosemicarbazide of 2-chlorobenzoic
acid, group IV—treated with 3-(2-chlorobenzoylami-
no-)-2-(o-tolylimino-)-4-methyl-4-selenazoline.
At the beginning of the experiment the weights of
rats were included within a range of 110–150 g.
Sodium selenite was given in form of water solution.
Organic compounds A and B given to groups III and IV
were suspended in the emulsion composed of oil,
Arabic gum and water in the following proportion
2:1:1.5. The administration was performed by stomach
tube. Selenium compounds were given to rats at a dose
of 5 9 10-4 mg of selenium/g of b.w. once a day for a
period of 10 days. Body weights of animals were
measured every day before selenium administration
and the appropriate amount of selenium compound was
calculated for each animal. The administered dose was
relatively high but it was applied with the aim of
studying toxicity of the new organoselenium com-
pounds. It is difficult to foresee the toxic dose of a new
compound as the bioavailability depends on its struc-
ture. The dose was chosen considering those applied by
other authors which were included in the range from
1 9 10-4 mg/g b.w. (Medeiros et al. 2012) to 19.7 9
10-4 mg/g b.w. (Selamoglu Talas et al. 2008), mainly
2 9 10-4–3 9 10-4 mg/g b.w. (El-Demerdash 2004;
Agarval and Behari 2007; Nazirog˘lu et al. 2008; Akil
et al. 2011a). Rats had free access to standard feed
containing adequate level of selenium and drinking
water. After the end of the experiment animals were
sacrificed under pentothal narcosis.
The study was performed according to statutory
bioethical standards and approved by I Local Ethical
Commission of Medical University of Lublin, accep-
tance no. 65/AM/2004.
Preparing of brain samples and measurement
of biochemical parameters
The samples of brain tissue were collected. Ten per cent
(w/v) tissue homogenates were prepared in 0.1 mol/dm3
Tris–HCl buffer, pH = 7.4. Supernatants were obtained
by centrifugation at 5,0009g for 30 min. The prepared
material was stored at temperature -18 C.
The following substances were determined in brain
homogenates: total antioxidant status (TAS), activity of
antioxidant enzymes—superoxide dismutase (SOD)
and glutathione peroxidase (GPx), concentrations of
non-enzymatic antioxidants—ascorbic acid (AA) and
reduced glutathione (GSH) as well as concentration of
lipid peroxidation marker—malonyl dialdehyde
(MDA). TAS was measured using diagnostic kit
produced by RANDOX and expressed in mmol/g of
protein. SOD and GPx activities were determined using
diagnostic kits RANSOD and RANSEL produced by
RANDOX and expressed in U/mg of protein and U/g of
protein, respectively. GSH concentration was deter-
mined using BIOXYTECH GSH-400TM kit produced
by OxisResearchTM and expressed in lg of GSH/mg of
protein. AA concentration was determined using mod-
ified Kyaw method (Rutkowski and Grzegorczyk 1998)
and expressed in lmol of AA/g of protein. MDA
concentration was determined using Ledwo_zyw et al.
(1986) method and expressed in nmol of MDA/mg of
protein. Protein was measured using method of Brad-
ford (1976). The assays were performed with use of
spectrophotometer SPECORD M40 (Zeiss Jena).
Statistical analysis
Statistical analysis was performed using ANOVA test.
Comparisons between control and selenium-supple-
mented groups as well as between selenium-supple-
mented groups were made using the Tukey’s HSD test
or Dunnett’s T3 test. Values were considered signif-
icant with p \ 0.05. The choice of multiple compar-
isons test was dependent on evaluation of variance
homogeneity in compared groups which was per-
formed using Leven’s test. In the event of homoge-
neous variances Tukey’s method of honestly
significant differences—HSD test was used, whereas
when variances in groups were heterogeneous
(p \ 0.05 in Leven’s test) T3 Dunnet’s test (applicable
in the case of heterogenous variances) was applied.
Results
TAS values were diminished in all selenium-supple-
mented groups, although this effect was not significant
versus control with no selenium supplementation.
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Activities of antioxidant enzymes GPx and SOD
were slightly increased versus control group in group
II (inorganic sodium selenite). In group III (organic
chain selenocompound) SOD was unchanged,
whereas GPx was markedly decreased versus control.
In group IV (organic ring selenocompound) both
enzymes were increased versus control, although this
effect was significant only in the case of GPx. In the
case of GPx organic forms of selenium displayed
insignificant differences when compared to inorganic
selenite—in group III (chain compound) GPx was
decreased versus group II, whereas in group IV (ring
derivative) enhancement versus group II was
observed. As concerns comparison between two
studied organic forms—the significant increase in
group IV versus group III was also observed.
Brain low-molecular antioxidants, AA and GSH
were influenced by selenium-administration in differ-
ent way, depending on the form of supplements. All
the studied selenium compounds insignificantly
decreased AA concentration versus control, whereas
chain selenosemicarbazide depleted it in well-marked
way versus group II (selenite). GSH was slightly
enhanced in group II, significantly depressed in group
III and practically unchanged in IV one in comparison
with control. Both selenoorganic compounds signifi-
cantly decreased GSH concentration in comparison
with inorganic selenite group.
MDA brain concentration was unaltered in rats of
group II (inorganic sodium selenite), significantly
decreased in group III and insignificantly increased in
group IV versus control. Organic forms of selenium
showed differences compared to inorganic selenite—
in group III (chain compound) well-marked decrease
in MDA versus group II, whereas in group IV (ring
selenocompound) slight enhancement versus group II
were observed. Moreover, there was the significant
increase in MDA in group IV versus group III.
All the obtained results are presented in Fig. 1.
Discussion
Selenium is an essential element and its deficit may
result in occurring of diverse disorders of organism
functions. Selenium supplementation has been found
to show beneficial effects in different pathological
states. On the other hand supplementation must be
carried out taking precautions as this element can
cause negative effects, including disturbances of
nervous system. Among other things, selenite was
found to cause irregular neurons growth in fish
embryos (Ma et al. 2012).
In the present study TAS was insignificantly
decreased in selenium-administered rats. The lack of
distinct relationships between selenium and TAS was
also reported by Okuonghae et al. (2011) who found
that in rats exposed to premium motor spirit fumes
well-marked increase in plasma selenium was accom-
panied with no significant changes of TAS value.
Another study also revealed no significant correlations
between selenium supplementation and blood TAS
(Savory et al. 2012). The decrease in TAS value
observed in our study can hardly be connected with the
changes of any other studied antioxidant. As distinct
from TAS changes these alterations depended on the
structure on the used selenocompound. It is possible
that TAS decrease could be related with other
substances of antioxidant properties. Among other
things some selenoproteins (selenoprotein P, thiore-
doxin reductases and methionine sulphoxide reductase
B) were found to act as antioxidants (Hoffmann et al.
2007; Steibrenner and Sies 2013). Further researches
including the influence of selenium supplementation
on expression of these proteins might contribute to the
clarification of this question. When considering
reported opinions on selenium supplementation and
our results (Herrmann et al. 2001; Feng et al. 2012),
measuring TAS is more recommended than determin-
ing changings of individual antioxidants.
Antioxidative enzymes GPx and SOD were
increased by inorganic selenium and selenoorganic
ring compound, whereas the chain derivative caused
their decrease versus control, although these effects
were significant only in the case of GPx in groups III
and IV (selenoorganic compounds). The outcomes of
the present study concerning sodium selenite admin-
istration are confirmed by other authors’ reports.
Sodium selenite increased SOD and GPx activity in
brain of cadmium-exposed as well as non-exposed
suckling rats. The applied dose and period of treatment
were comparable—0.632 mg selenium/kg b.w. and
9 days, respectively (Lazarus et al. 2011) to those used
in the present experiment. In mice treated with
methylmercury GPx activity in cerebral cortex was
decreased and co-administration of sodium selenite
did not exert any influence, whereas in non-exposed
animals increase in GPx was observed (Glaser et al.
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2010). Selenium given as sodium selenite increased
GPx activity in cerebrum and cerebellum of suckling
rats whose mother were administered methimazole
during pregnancy and lactation. The same significant
enhancement was observed in animals with no meth-
imazole treatment. In the case of SOD increase was
shown only in cerebellum of animals treated
with methimazole, whereas in untreated selenium
displayed no effect (Ben Amara et al. 2009).
As far as selenoorganic compounds are concerned
the outcomes of the present study and others are
divergent than what seems to be connected with
different structures of the administered selenocom-
pounds. Administration of DL-selenomethionine to
mercury-exposed rat pups whose mothers were also
subjected to the same treatment during pregnancy
resulted in significant increase in hippocampal SOD
activity (Su et al. 2008). Medeiros et al. (2012) found
that selenoorganic compound of chain structure
increased SOD activity only in the rat hippocampus,
whereas GPx was reduced in all studied brain struc-
tures (cerebral cortex, hippocampus and cerebellum).
In the present experiment the same result was obtained
with regard to GPx in group III receiving chain
selenocompound. Different results were obtained by
Selamoglu Talas et al. In rats exposed to carcinogenic
hydrocarbon, selenium, administered in form of two
selenones, caused increase in both studied enzymes’
activity (Selamoglu Talas et al. 2008). The differences
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Fig. 1 Effect of selenium
supplementation on
oxidative parameters in
brain of rats. Rats were
randomly divided into four
groups (10 animals each)
and intragastrically treated
with: saline (group I);








Data are means ± SD.
*p \ 0.05; ***p \ 0.001
versus group I Ap \ 0.05;
Bp \ 0.01; Cp \ 0.001
versus group II Xp \ 0.05;
Yp \ 0.01; versus group III
(H) Tukey’s HSD test
(D) T3 Dunnett’s test
Biometals (2013) 26:763–771 767
123
from the fact that in the present work the period of
selenium administration was shorter. This assumption
seems to be confirmed by observations reported by
Ozkan et al. (2007) who found that in mice, exposed to
cigarette smoke and selenium in form of L-selenome-
thionine, no significant changes of SOD and GPx were
observed after 3 months, whereas after 5 months both
enzymes were found to be increased. The significant
decrease in GPx observed in the present study in group
III could be caused by the comparatively great dose,
whereas no changes or increase reported by Ozkan
et al. may result from adaptive mechanism developed
by organism during longer time of exposure.
Low-molecular antioxidants AA and GSH were not
markedly influenced versus control in the present
study, except for GSH in group III. Similarly, Agarval
and Behari (2007) found that sodium selenite did not
influence GSH concentration in brain of healthy and
mercury-exposed rats. Sodium selenite showed ame-
liorating effect consisting in significant increase in
GSH as well as in vitamin C concentration in cerebrum
and cerebellum of rats undergoing exposure to chro-
mium, whereas in non-exposed animals no significant
effects were observed (Soudani et al. 2012), which
confirms outcomes of the present study. Other scien-
tists reported different outcomes but their experiments
concerned selenium influence in animals additionally
exposed to pathogenic factors. Nazirog˘lu et al. (2008)
reported that in rats with pentylentetrazol-induced
seizures earlier selenium administration resulted in
both GSH and AA increase in cortex brain. As for
GSH other studies were consistent with findings
reported by Nazirog˘lu et al. In mercury-exposed rat
pups whose mothers were also subjected to the same
treatment during pregnancy DL-selenomethionine
caused significant increase in hippocampal GSH
concentration (Su et al. 2008). Increase in GSH
concentration in rats exposed to carcinogenic hydro-
carbon and receiving two selenooorganic compounds
(selenones) was also observed by Selamoglu Talas
et al. (2008). Selenium given as sodium selenite
increased GSH concentration in cerebrum and cere-
bellum of suckling rats whose mothers were treated
with methimazole during pregnancy and lactation. The
similar significant enhancement was observed in
animals with no methimazole treatment (Ben Amara
et al. 2009).
In the present study MDA, a marker of lipid
peroxidation, was not significantly influenced versus
control, except for group III. The studies performed by
other researchers are consistent with our results
concerning inorganic selenite. In brain of healthy
and mercury-exposed rats sodium selenite did not
change MDA concentration (Agarval and Behari
2007). The similar effects were reported by Akil
et al. (2011a, b) who stated no effect of selenium
supplementation (sodium selenite at two different
doses: 6 mg/kg/day and 600 lg/kg/day) on MDA
values in brain tissue and blood samples, respectively.
Sodium selenite did not affect MDA concentration in
cerebrum and cerebellum of suckling rats whose
mothers were treated with methimazole during preg-
nancy and lactation. The same lack of influence was
displayed in animals without methimazole adminis-
tration (Ben Amara et al. 2009). In some cases of
additional poisoning with heavy metals the outcomes
of other authors were different. Sodium selenite given
to rats did not influence distinctly brain TBARS
(thiobarbituric acid-reactive substances) level in
healthy animals, but in those exposed to aluminium
significant decrease was observed (El-Demerdash
2004). Sodium selenite depressed TBARS in brain of
suckling rats exposed to cadmium, whereas in non-
exposed no significant influence was obtained (Laz-
arus et al. 2011). Similarly, sodium selenite exerted
ameliorating effects on lipid peroxidation induced in
rat cerebrum and cerebellum by chromium intoxica-
tion. MDA concentration was found to be significantly
decreased. In non-exposed rats no influence was
observed (Soudani et al. 2012).
The results concerning organic selenium are not
consistent. It can be connected with the fact that
administered compounds had different structures.
Differences could also be the consequences of the
additional pathogenic factors to which animals were
exposed. Hippocampal MDA concentration in rat pups
exposed to mercury and receiving selenium in form of
DL-selenomethionine, whose mothers were also sub-
jected to the same treatment during pregnancy, was
significantly increased (Su et al. 2008). Administration
of selenium, in form of two organic compounds
(selenones), to rats exposed to carcinogenic hydrocar-
bon resulted in distinct decrease in MDA concentra-
tion (Selamoglu Talas et al. 2008). Organoselenium
compound of chain structure did not influence in well-
marked way TBARS in rat hippocampus and cerebel-
lum, whereas enhancement in the cerebral cortex was
observed (Medeiros et al. 2012). Insignificant increase
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was observed in the present work in group IV, but the
time of administration was considerably shorter (10
vs. 30 days).
Interestingly, in the present study the changes of GPx
activity and GSH concentration were practically the
same in groups II and III. In vitro study performed on
cortical neurons of rat fetuses treated with organosele-
nium ring compound (ebselen) showed that concentra-
tion of GSH increased up to specific value of ebselen
concentration. Further enhancement of ebselen concen-
tration did not influence GSH concentration (Pawlas and
Małecki 2007). Venardos et al. (2004) observed the
similar dependence between liver GPx activity and
selenium level in diet of experimental animals. It points
that GSH, similarly as GPx activity, increases in
selenium-dose-dependent way till a kind of ‘‘saturation’’
occurs. These observations are consistent, considering
the fact that GSH is a substrate for GPx.
Selenium supplementation was found to show bene-
ficial effect in cases of disturbances of nervous system.
The study performed on rats revealed that selenium can
slow down neurodegenerative processes (Zafar et al.
2003). Supplementation with micronutrients including
selenium was revealed to improve symptoms of depres-
sion in older people (Gosney et al. 2008) and sodium
selenite was suggested to be a promising compound for
treatment of Alzheimer’s disease (van Eersel et al. 2010).
However, some authors reported opposite opinions (Loef
et al. 2011). Vinceti et al. (2010) hypothesized that dietary
inorganic selenium may increase the risk of amyotrophic
lateral sclerosis. Organic selenocompounds were studied
in regard to their application in neurodegenerative
diseases and the results were promising (Jauslin et al.
2002). Considering the possibility of the application of
the studied compounds A and B as selenium-supple-
ments, the outcomes of the present study show that
although chain selenosemicarbazide significantly
decreased lipid peroxidation level, it also caused impair-
ment of antioxidant defence. 3-(2-chlorobenzoylamino-
)-2-(o-tolylimino-)-4-methyl-4-selenazoline of cyclic
structure seems to be a more promising agent for future
studies since it did not decrease elements of antioxidant
barrier and increased GPx activity. As selenium is a
constituent of GPx it could point that the bioavailability of
selenazoline is better than that of selenosemicarbazide.
Concluding, further studies with use of selenazoline
appear to be advisable to evaluate its possible application
as a selenium-supplement. As sex differences regarding
selenium in vertebrates were reported (Raman et al. 2012)
subsequent studies should include female rats.
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